Endotherapy Devices Market Size - By Product (Gastrointestinal Devices & Accessories {Biopsy Forceps}, Endoscopic Retrograde Cholangio Pancreatography (ERCP) Devices & Accessories), End-use (Hospitals, Ambulatory Surgical Centres) & Forecast, 2024 – 2032

Endotherapy Devices Market Size

Endotherapy Devices Market size was valued at USD 4.8 billion in 2023 and is anticipated to grow at a CAGR of 7.8% between 2024 and 2032, driven by the rising incidence of gastrointestinal conditions, increasing preference for minimally invasive procedures, and increasing awareness towards early diagnosis and treatment of GI disorders.
 

Gastrointestinal diseases, including conditions such as inflammatory bowel disease (IBD), colorectal cancer, gastroesophageal reflux disease (GERD), and peptic ulcers, are becoming increasingly prevalent worldwide. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2023, about 7 million people worldwide were estimated to have IBD. With the rising incidence of GI conditions, there is a corresponding increase in the number of diagnostic and therapeutic procedures performed to manage these diseases.
 

Additionally, endotherapy devices enable minimally invasive procedures, which are preferred over traditional surgical methods due to their reduced risk, shorter recovery times, and lower healthcare costs. Patients with GI conditions increasingly opt for endoscopic treatments, such as polypectomy, mucosal resection, and stent placement, which are less invasive and offer quicker recovery. This preference for minimally invasive procedures boosts the market for endotherapy devices.
 

Endotherapy devices are specialized medical instruments and tools used in endoscopic procedures to diagnose, treat, and manage various gastrointestinal and respiratory conditions.
 

Endotherapy Devices Market Trends

Innovations in medical technology have led to the development of more effective, efficient, and safer endotherapy devices, enhancing their use in diagnosing and treating gastrointestinal (GI) conditions.
 

• One of the major advancements in endotherapy is the improvement in imaging technologies. High-definition (HD) endoscopes, narrow-band imaging (NBI), and confocal laser endomicroscopy (CLE) provide clearer and more detailed images of the GI tract. These technologies enable better visualization of mucosal structures, aiding in the accurate diagnosis of GI conditions and early detection of malignancies. The increased gastrointestinal diagnostics accuracy drives the demand for advanced endotherapy devices.
   
• Additionally, technological innovations have led to the development of endotherapy devices with improved design and functionality. For example, the introduction of flexible and ultra-thin endoscopes allows for easier navigation through the GI tract, reducing patient discomfort and improving procedural outcomes. Devices like single-use endoscopes also minimize the risk of cross-contamination and infection, enhancing patient safety and driving their adoption.
   
• Furthermore, technological advancements have expanded the therapeutic capabilities of endotherapy devices. Techniques such as endoscopic submucosal dissection (ESD), peroral endoscopic myotomy (POEM), and endoscopic mucosal resection (EMR) allow for minimally invasive treatment of complex GI conditions. These advanced procedures offer benefits such as reduced recovery times, lower complication rates, and better clinical outcomes, increasing the demand for specialized endotherapy devices.
   

Endotherapy Devices Market Analysis

Based on product, the market is segmented into gastrointestinal devices & accessories, endoscopic retrograde cholangio pancreatography (ERCP) devices & accessories, and other products. The gastrointestinal devices & accessories segment held a dominant market share of 56.6% in 2023.
 

• The GI devices and accessories segment encompasses a broad array of products, including biopsy devices, injection needles, polypectomy snares, graspers, hemoclips, endoscopic submucosal dissection knives, hemostasis forceps, sclerotherapy needles, etc. This comprehensive range addresses the diverse needs of gastroenterologists and endoscopists, providing them with the tools necessary for a variety of diagnostic and therapeutic procedures. The extensive product portfolio contributes to the segment's significant market share.
   
• Additionally, gastrointestinal conditions require accurate and timely diagnosis. Endoscopic procedures are the gold standard for diagnosing these conditions, driving the demand for GI devices and accessories. The increasing prevalence of GI disorders and the emphasis on early detection and screening programs further boost the demand for diagnostic endotherapy devices.
   

Based on end-use, the endotherapy devices market is categorized into hospitals, ambulatory surgical centers, and other end-users. The hospitals segment market size in 2023 was valued at USD 2.7 billion.
 

• Hospitals typically handle a large volume of patients, including those requiring endoscopic procedures for various gastrointestinal (GI) conditions. The high patient inflow ensures a consistent and substantial demand for endotherapy devices. Hospitals cater to both routine diagnostic procedures and complex therapeutic interventions, driving the extensive use of these devices.
   
• Additionally, hospitals employ skilled and experienced medical professionals, including gastroenterologists, endoscopists, and surgeons, who are proficient in performing endoscopic procedures. The expertise of these professionals ensures the accurate diagnosis and effective treatment of GI conditions using endotherapy devices. The reliance on expert care in hospitals boosts the demand for these devices.
   

North America endotherapy devices market size in 2023 was valued at USD 2.2 billion and is predicted to grow at a CAGR of 7.5% over the analysis timeframe.
 

• North America holds a significant market share in the market, driven by advanced healthcare infrastructure, high healthcare expenditure, and the presence of leading medical device companies.
   
• Additionally, the region's well-established healthcare systems and the increasing prevalence of gastrointestinal (GI) disorders contribute to the substantial demand for endotherapy devices. The adoption of cutting-edge technologies and the availability of skilled healthcare professionals further bolster the market.
   

The U.S. endotherapy devices market is anticipated to grow at a CAGR of 7.4% to reach USD 4 billion by the end of the forecast timeframe.
 

• The country's significant investment in healthcare research and development (R&D) leads to continuous innovation in endoscopic technologies. The high incidence of GI diseases, coupled with the growing awareness of early diagnosis and treatment, drives the demand for advanced endotherapy devices.
   
• The presence of key market players and robust healthcare infrastructure in the U.S. ensures the availability and adoption of these devices across a wide range of healthcare settings, including hospitals and specialized endoscopy centers.
   

Germany endotherapy devices market is projected to grow remarkably in the coming years.
 

• The country's strong emphasis on healthcare quality and technological advancement positions it as a leader in the adoption of innovative medical devices. Germany's well-developed healthcare system, combined with a high prevalence of GI disorders, creates a favorable environment for the utilization of endotherapy devices.
   
• Additionally, the country's regulatory framework supports the approval and implementation of advanced endoscopic technologies.
   
• Moreover, Germany's role as a hub for medical device manufacturing and research further strengthens its market share in the market.
   

Japan is experiencing high market growth in the endotherapy devices market.
 

• The country's healthcare system is renowned for its technological advancements and high standards of care, contributing to the widespread adoption of endotherapy devices.
   
• The government's support for healthcare innovation and investment in medical R&D fosters the development and utilization of advanced endoscopic technologies.
   
• Additionally, the focus on minimally invasive procedures aligns with the increasing preference for endotherapy devices, further solidifying its market share.
   

Endotherapy Devices Market Share

The endotherapy devices industry is characterized by the presence of several established and emerging players that offer a variety of products across the globe. The market players compete based on factors such as product quality, innovation, regulatory compliance, customer service, and pricing strategies.
 

Endotherapy Devices Market Companies

Prominent players operating in the endotherapy devices industry include:

• B.Braun
• Boston Scientific Corporation
• Conmed Corporation
• Cook Medical
• Fujifilm Corporation
• Intuitive Surgical
• Johnson & Johnson
• Karl Storz
• M.I. Tech Co Ltd
• Medtronic plc
• Olympus Corporation
• Richard Wolf GmbH
• Smith & Nephew PLC
• Stryker Corporation
• TaeWoong Medical Co., Ltd.
   

Endotherapy Devices Industry News

• In June 2024, B. Braun announced the launch of its new ACCEL All-Purpose and Biliary Drainage Catheters with TrueGlide Hydrophilic Coating for percutaneous drainage. The catheter features large oval holes designed to maximize fluid drainage volume, while the TrueGlide Hydrophilic Coating helps with a smooth catheter insertion. This product launch may help the company to enhance its business revenue.
   
• In May 2024, Cook Medical launched the next-generation EchoTip AcuCore Endoscopic Ultrasound (EUS) Biopsy Needle in the U.S. The AcuCore needle is designed with a Franseen tip made of a cobalt chromium alloy, which allows physicians to puncture tissue with flexibility, minimum force and controlled precision. This product launch may help the company to enhance its product portfolio and offerings to customers.
   

The endotherapy devices market research report includes in-depth coverage of the industry with estimates & forecasts in terms of revenue in USD Million from 2021 - 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Gastrointestinal devices & accessories
  • Biopsy forceps
    • Single-use biopsy forceps
    • Reusable biopsy forceps
    • Hot biopsy forceps
  • Injection needles
    • EUS-guided FNA (fine needle aspiration) needles
    • EUS-guided FNB (fine needle biopsy) needles
    • Other injection needles
  • Polypectomy snares
  • Graspers
  • Hemoclips
  • Endoscopic submucosal dissection (ESD) knives
    • Insulation-tipped knives
    • Needle-tipped knives
  • Hemostasis forceps
  • Sclerotherapy needles
  • Other gastrointestinal devices & accessories 
• Endoscopic retrograde cholangio pancreatography (ERCP) devices & accessories
  • Guide wire
  • Sphincterotome
  • Catheter
    • Drainage catheter
    • Dilation catheter
    • Guiding catheter
    • Other catheters
  • Extraction basket
  • Extraction balloon
  • Balloon dilation
  • Plastic stents
  • Metal stents
  • Other ERCP devices & accessories
• Other products

Market, By End-use

• Hospitals
• Ambulatory surgical centers
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa